| Remington's Pharmaceutical Sciences
| [0017]
|
| Degradable Clostridial Toxins
| [0027]
|
| Activatable Clostridial Toxins
| [0029]
|
| Modified Clostridial Toxins with Enhanced Translocation Capabilities and Altered Targeting Activity For Non-Clostridial Toxin Target Cells
| [0029]
|
| Modified Clostridial Toxins with Enhanced Translocation Capabilities and Altered Targeting Activity for Clostridial Toxin Target Cells
| [0029]
|
| Degradable Clostridial Toxins
| [0029]
|
| Activatable Clostridial toxins
| [0029]
|
| Modified Clostridial Toxins Comprising an Integrated Protease Cleavage Site-Binding Domain
| [0029]
|
| Methods of Intracellular Conversion of Single-Chain Proteins into their Di-chain Form
| [0029]
|
| PHARMACEUTICAL DOSAGE FORMS AND DRUG DELIVERY SYSTEMS
| [0062]
|
| REMINGTON: THE SCIENCE AND PRACTICE OF PHARMACY
| [0062]
|
| GOODMAN & GILMAN'S THE PHARMACOLOGICAL BASIS OF THERAPEUTICS
| [0062]
|
| HANDBOOK OF PHARMACEUTICAL EXCIPIENTS
| [0062]
|
| Clostridial Toxin Pharmaceutical Compositions
| [0063]
|